CoChat
Sign Up
Cited by 433

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway

Wielenga, Vera J.M., Smits, Ron, Korinek, Vladimir, Smit, Lia, Kielman, Menno, Fodde, Riccardo, Clevers, Hans, Pals, Steven T.·1999·The American Journal of Pathology
DOI 10.1016/s0002-9440(10)65297-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)65297-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 62

  1. Vogelstein, 1988, Genetic alterations during colorectal-tumor development, N Engl J Med, 319, 525, 10.1056/NEJM198809013190901 · DOI
  2. Nagase, 1993, Mutations of the APC (adenomatous polyposis coli) gene, Hum Mutat, 2, 425, 10.1002/humu.1380020602 · DOI
  3. Rubinfeld, 1993, Association of the APC gene product with β-catenin, Science, 262, 1731, 10.1126/science.8259518 · DOI
  4. Gumbiner, 1990, Generation and maintenance of epithelial cell polarity, Curr Opin Cell Biol, 2, 881, 10.1016/0955-0674(90)90087-U · DOI
  5. Behrens, 1996, Functional interaction of β-catenin with the transcription factor LEF-1, Nature, 382, 638, 10.1038/382638a0 · DOI · Paper page
  6. Molenaar, 1996, Xtcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos, Cell, 86, 391, 10.1016/S0092-8674(00)80112-9 · DOI · Paper page
  7. Korinek, 1997, Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma, Science, 275, 1784, 10.1126/science.275.5307.1784 · DOI · Paper page
  8. Morin, 1997, Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC, Science, 275, 1787, 10.1126/science.275.5307.1787 · DOI
  9. Rubinfeld, 1997, Stabilization of β-catenin by genetic defects in melanoma cell lines, Science, 275, 1790, 10.1126/science.275.5307.1790 · DOI
  10. Lesley, 1993, CD44 and its interactions with the extracellular matrix, Adv Immunol, 4, 271, 10.1016/S0065-2776(08)60537-4 · DOI
  11. Stamenkovic, 1989, A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family, Cell, 56, 1057, 10.1016/0092-8674(89)90638-7 · DOI
  12. Günthert, 1991, A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cell lines, Cell, 65, 13, 10.1016/0092-8674(91)90403-L · DOI
  13. Screaton, 1992, Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons, Proc Natl Acad Sci USA, 89, 12160, 10.1073/pnas.89.24.12160 · DOI
  14. Jalkanen, 1987, Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85–95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells, J Cell Biol, 105, 983, 10.1083/jcb.105.2.983 · DOI
  15. Degrendle, 1997, Requirement for CD44 in activated T cell extravasation into an inflammatory site, Science, 278, 672, 10.1126/science.278.5338.672 · DOI
  16. Miyake, 1990, Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures, J Exp Med, 171, 477, 10.1084/jem.171.2.477 · DOI
  17. Horst, 1990, Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM (CD54), Leukemia, 4, 595
  18. Jalkanen, 1991, Lymphocyte homing and clinical behaviour of non-Hodgkin's lymphoma, J Clin Invest, 87, 1835, 10.1172/JCI115205 · DOI
  19. Sy, 1992, Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein, J Exp Med, 176, 623, 10.1084/jem.176.2.623 · DOI
  20. Koopman, 1993, Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44, J Exp Med, 177, 897, 10.1084/jem.177.4.897 · DOI
  21. Stauder, 1995, CD44 variant isoforms in non-Hodgkin's lymphomas: a new independent prognostic factor, Blood, 85, 2885, 10.1182/blood.V85.10.2885.bloodjournal85102885 · DOI
  22. Matsumara, 1992, Significance of CD44 gene products for cancer diagnosis and disease evaluation, Lancet, 340, 1053, 10.1016/0140-6736(92)93077-Z · DOI
  23. Wielenga, 1993, Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression, Cancer Res, 53, 4754
  24. Kauffmann, 1995, CD44 variant exon epitopes in primary breast cancer and length of survival, Lancet, 345, 615, 10.1016/S0140-6736(95)90521-9 · DOI
  25. Lacy, 1987, The hyaluronate receptor is associated with actin filaments, J Cell Biol, 105, 1395, 10.1083/jcb.105.3.1395 · DOI
  26. Aruffo, 1990, CD44 is the principal cell surface receptor for hyaluronate, Cell, 61, 1303, 10.1016/0092-8674(90)90694-A · DOI
  27. Kalomiris, 1988, Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin, J Cell Biol, 106, 319, 10.1083/jcb.106.2.319 · DOI
  28. Tsukita, 1994, ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons, J Cell Biol, 126, 391, 10.1083/jcb.126.2.391 · DOI
  29. Jackson, 1995, Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon, J Cell Biol, 128, 673, 10.1083/jcb.128.4.673 · DOI
  30. Bennett, 1995, CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor, J Cell Biol, 128, 687, 10.1083/jcb.128.4.687 · DOI
  31. van der Voort R, Taher TEI, Wielenga VJM, Prevo R, Smit C, David G, Hartmann G, Gherhardi E, Pals ST: Hepatocyte growth factor/scatter factor presentation by a CD44 splice variant promotes signaling through c-Met receptor tyrosine kinase in tumor cells. J Biol Chem 1999 (in press) · DOI
  32. Tanaka, 1993, T-cell adhesion induced by proteoglycan immobilized MIP-1b, Nature, 361, 69, 10.1038/361079a0 · DOI
  33. Heider, 1993, A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps, J Cell Biol, 120, 227, 10.1083/jcb.120.1.227 · DOI
  34. Mulder, 1995, Colorectal cancer prognosis and expression of exon-v6 containing CD44 proteins, Lancet, 344, 1470, 10.1016/S0140-6736(94)90290-9 · DOI
  35. Kim, 1994, CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 mutation, Arch Biochem Biophys, 310, 504, 10.1006/abbi.1994.1199 · DOI
  36. Ropponen, 1998, Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis, Scand J Gastroenterol, 33, 303
  37. Yamaguchi, 1996, Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients, J Clin Oncol, 14, 1122, 10.1200/JCO.1996.14.4.1122 · DOI
  38. Imazeki, 1996, Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans, Gastroenterology, 110, 362, 10.1053/gast.1996.v110.pm8566581 · DOI
  39. Wielenga, 1998, CD44 splice variants as prognostic markers in colorectal cancer, Scand J Gastroenterol, 33, 82, 10.1080/00365529850166257 · DOI
  40. Korinek, 1998, Absence of epithelial stem cell compartments in Tcf-4−/− small intestine, Nature Genet, 19, 379, 10.1038/1270 · DOI
  41. Heider, 1996, Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas, Cancer Immunol Immunother, 43, 245, 10.1007/s002620050329 · DOI
  42. Weiss, 1997, An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function, J Cell Biol, 137, 1137, 10.1083/jcb.137.5.1137 · DOI
  43. van der Voort, 1997, Paracrine regulation of germinal center B cell adhesion through the c-Met-hepatocyte growth factor/scatter factor pathway, J Exp Med, 185, 2121, 10.1084/jem.185.12.2121 · DOI
  44. Jen, 1994, Molecular determinants of dysplasia in colorectal lesions, Cancer Res, 54, 5523
  45. Smits, 1997, Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis, Carcinogenesis, 18, 321, 10.1093/carcin/18.2.321 · DOI
  46. He, 1998, Identification of c-Myc as a target of the APC pathway, Science, 281, 1509, 10.1126/science.281.5382.1509 · DOI · Paper page
  47. Furuta, 1996, Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms, Am J Pathol, 149, 1147
  48. Moser, 1992, The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system, J Cell Biol, 116, 1517, 10.1083/jcb.116.6.1517 · DOI
  49. Bartolazzi, 1994, Interaction between CD44 and hyaluronate is directely implicated in the regulation of tumor development, J Exp Med, 180, 53, 10.1084/jem.180.1.53 · DOI
  50. Yu, 1997, Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function, J Exp Med, 186, 1985, 10.1084/jem.186.12.1985 · DOI
  51. Ruoslahti, 1991, Proteoglycans as modulators of growth factor activities, Cell, 64, 867, 10.1016/0092-8674(91)90308-L · DOI
  52. Schlessinger, 1995, Regulation of growth factor activation by proteoglycans. What is the role of the low affinity receptors?, Cell, 83, 357, 10.1016/0092-8674(95)90112-4 · DOI
  53. Weidner, 1990, Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells, J Cell Biol, 111, 2097, 10.1083/jcb.111.5.2097 · DOI
  54. Giordano, 1993, Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene, Proc Natl Acad Sci USA, 90, 649, 10.1073/pnas.90.2.649 · DOI
  55. Rong, 1994, Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation, Proc Natl Acad Sci USA, 91, 4731, 10.1073/pnas.91.11.4731 · DOI
  56. Di Renzo, 1995, Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer, Clin Cancer Res, 1, 147
  57. Liu, 1992, Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas, Oncogene, 7, 181
  58. Prat, 1991, The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors, Int J Cancer, 49, 323, 10.1002/ijc.2910490302 · DOI
  59. Reichsman, 1996, Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction, J Cell Biol, 135, 819, 10.1083/jcb.135.3.819 · DOI
  60. Binari, 1997, Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling, Development, 124, 2623, 10.1242/dev.124.13.2623 · DOI
  61. Haerry, 1997, Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila, Development, 124, 3055, 10.1242/dev.124.16.3055 · DOI
  62. Sonnenberg, 1993, Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development, J Cell Biol, 123, 223, 10.1083/jcb.123.1.223 · DOI

Cited by

Sorted by citations

Metadata

Authors
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., & Pals, S. T.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
1999-02
Volume
154
Issue
2
Pages
515-523
ISSN
0002-9440
DOI
10.1016/s0002-9440(10)65297-2
Cited by
433
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review